US 7,119,200 B2 · Pyrazolopyrimidines as cyclin dependent kinase inhibitors

Pyrazolopyrimidines as cyclin dependent kinase inhibitors

AssigneesSchering Corporation, Pharmacopeia Drug Discovery, Inc.

InventorsTimothy J. Guzi, Kamil Paruch, Michael P. Dwyer, Ronald J. Doll, Viyyoor M. Girijavallabhan, Alan Mallams, Carmen S. Alvarez, Kartik M. Keertikar, Jocelyn Rivera, Tin-Yau Chan, Vincent Madison, Thierry O. Fischmann, Lawrence W. Dillard, Vinh D. Tran, Zhen Min He, Ray Anthony James, Haengsoon Park, Vidyadhar M. Hobbs, Douglas Walsh Hobbs

Life of this patent

Estimating the term…

Abstract

In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.

Claims13

Dependent claims

A compound of the formula:

or a pharmaceutically acceptable salt thereof.

Dependencies are inferred from the claim text.